Akebia stock on the rise after upsized $100M IPO
March 20, 2014 at 14:08 PM EDT
Continuing the unprecedented success of biotech IPOs in recent months, shares of anemia drug developer Akebia Therapeutics were up 35 percent as of 2 p...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|